BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24857257)

  • 1. [Malignant insulinoma: recommendations for workup and treatment].
    Baudin E; Caron P; Lombard-Bohas C; Tabarin A; Mitry E; Reznick Y; Taieb D; Pattou F; Goudet P; Vezzosi D; Scoazec JY; Cadiot G; Borson-Chazot F; Do Cao C;
    Presse Med; 2014 Jun; 43(6 Pt 1):645-59. PubMed ID: 24857257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of malignant insulinoma responsive to somatostatin analogs treatment.
    Caliri M; Verdiani V; Mannucci E; Briganti V; Landoni L; Esposito A; Burato G; Rotella CM; Mannelli M; Peri A
    BMC Endocr Disord; 2018 Dec; 18(1):98. PubMed ID: 30591061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: case report and review of the literature.
    Scharf M; Mueller D; Koenig U; Pfestroff A; Nimphius W; Figiel J; Rinke A; Koenig A; Gress T
    Pancreatology; 2014; 14(6):542-5. PubMed ID: 25459566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of malignant pancreatic endocrine tumour.
    Wang L; Zhao YP; Lee CI; Liao Q
    Chin Med Sci J; 2004 Jun; 19(2):130-3. PubMed ID: 15250251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant insulinoma].
    Tóth M; Szücs N; Jakab Z; Doros A; Nemes Z; Rácz K
    Orv Hetil; 2011 Mar; 152(10):398-402. PubMed ID: 21354956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant insulinoma misdiagnosed and treated as epilepsy.
    Louda F; Chadli A; Elaziz S; Elghomari H; Farouqi A
    Ann Endocrinol (Paris); 2013 Feb; 74(1):53-5. PubMed ID: 23351560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of insulin-secreting pancreatic islet cell tumors in ferrets: 57 cases (1986-1994).
    Caplan ER; Peterson ME; Mullen HS; Quesenberry KE; Rosenthal KL; Hoefer HL; Moroff SD
    J Am Vet Med Assoc; 1996 Nov; 209(10):1741-5. PubMed ID: 8921033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinoma: a review of current management.
    Bliss RD; Carter PB; Lennard TW
    Surg Oncol; 1997; 6(1):49-59. PubMed ID: 9364660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant insulinoma: Report of 6 patients and literature review.
    Shao Y; Qu YQ; Wang XL; Song ZG; Guo QH; Dou JT; Ba JM; Lü ZH; Mu YM
    Neuro Endocrinol Lett; 2016 Jul; 37(3):189-192. PubMed ID: 27618603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulinoma: what symptomatology?].
    Uebersax R; Cananau S; Beuret P; Zahnd G
    Rev Med Suisse Romande; 1984 Sep; 104(9):733-8. PubMed ID: 6095399
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of insuloma patients with refractory hypoglycemia.
    Meleo K
    Probl Vet Med; 1990 Dec; 2(4):602-9. PubMed ID: 1983699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant insulinoma: recommendations for characterisation and treatment.
    Baudin E; Caron P; Lombard-Bohas C; Tabarin A; Mitry E; Reznick Y; Taieb D; Pattou F; Goudet P; Vezzosi D; Scoazec JY; Cadiot G; Borson-Chazot F; Do Cao C; ;
    Ann Endocrinol (Paris); 2013 Dec; 74(5-6):523-33. PubMed ID: 23993836
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of malignant insulinoma.
    Ferrer-García JC; Iranzo González-Cruz V; Navas-DeSolís S; Civera-Andrés M; Morillas-Ariño C; Merchante-Alfaro A; Caballero-Díaz C; Sánchez-Juan C; Camps Herrero C
    Clin Transl Oncol; 2013 Sep; 15(9):725-31. PubMed ID: 23460559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatment.
    Rott G; Biggemann M; Pfohl M
    Cardiovasc Intervent Radiol; 2008; 31(3):659-62. PubMed ID: 17922161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma of genetic aetiology.
    Borson-Chazot F; Cardot-Bauters C; Mirallie É; Pattou F;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):200-2. PubMed ID: 23769271
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades.
    Yu J; Ping F; Zhang H; Li W; Yuan T; Fu Y; Feng K; Xia W; Xu L; Li Y
    BMC Endocr Disord; 2018 Dec; 18(1):92. PubMed ID: 30522468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors of the pancreas.
    Miglani A; Kar P
    Trop Gastroenterol; 2006; 27(1):4-10. PubMed ID: 16910053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective therapeutic embolization in malignant insulinoma].
    Civera Andrés M; Real Collado JT; Martínez Usó I; Ampudia Blasco FJ; Carmena Rodríguez R
    Rev Clin Esp; 2000 Oct; 200(10):548-50. PubMed ID: 11153238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Insulinoma Is Largely Derived From Nonfunctioning Pancreatic Neuroendocrine Tumors: A Contemporary View.
    Yu R
    Pancreas; 2020 Jul; 49(6):733-736. PubMed ID: 32590616
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulinoma-associated transient hypothalamus-pituitary-adrenal axis impairment and amelioration by steroid therapy and surgical intervention: a case report.
    Chang YH; Hsieh MC; Hsin SC; Shin SJ; Lin KD
    Kaohsiung J Med Sci; 2007 Oct; 23(10):526-30. PubMed ID: 18055299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.